AMPKα Cancer Research Results

AMPKα, AMP-activated protein kinase: Click to Expand ⟱
Source:
Type:
AMPK is a heterotrimeric protein complex consisting of three subunits: AMPKα, AMPKβ, and AMPKγ. AMPKα is expressed in two isoforms, AMPKα1 and AMPKα2, and these isoforms are encoded by the genes PRKAA1 and PRKAA2, respectively.
In many cancers, AMPKα acts as a tumor suppressor, and its downregulation is often associated with worse clinical outcomes.


Scientific Papers found: Click to Expand⟱
940- BBR,    Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression
- vitro+vivo, PC, PANC1 - in-vivo, PC, MIA PaCa-2
LDHA↓, lactateProd↓, AMPKα↓, TumVol↓, Ki-67↓,
82- QC,  ATG,    Arctigenin in combination with quercetin synergistically enhances the anti-proliferative effect in prostate cancer cells
- in-vitro, Pca, LNCaP
AR↓, PI3K/Akt↓, miR-21↓, STAT3↓, BAD↓, PRAS40↓, GSK‐3β↓, PSA↓, NKX3.1↑, Bax:Bcl2↑, miR-19b↓, miR-148a↓, AMPKα↓, TumCP↓, chemoPv↑, TumCMig↓,

Showing Research Papers: 1 to 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2

Pathway results for Effect on Cancer / Diseased Cells:


Core Metabolism/Glycolysis

lactateProd↓, 1,   LDHA↓, 1,   PI3K/Akt↓, 1,  

Cell Death

BAD↓, 1,   Bax:Bcl2↑, 1,  

Kinase & Signal Transduction

AMPKα↓, 2,  

Transcription & Epigenetics

miR-21↓, 1,  

DNA Damage & Repair

NKX3.1↑, 1,  

Proliferation, Differentiation & Cell State

GSK‐3β↓, 1,   STAT3↓, 1,  

Migration

Ki-67↓, 1,   miR-148a↓, 1,   miR-19b↓, 1,   TumCMig↓, 1,   TumCP↓, 1,  

Immune & Inflammatory Signaling

PSA↓, 1,  

Hormonal & Nuclear Receptors

AR↓, 1,  

Clinical Biomarkers

AR↓, 1,   Ki-67↓, 1,   PSA↓, 1,  

Functional Outcomes

chemoPv↑, 1,   PRAS40↓, 1,   TumVol↓, 1,  
Total Targets: 23

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: AMPKα, AMP-activated protein kinase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:475  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page